Peter Thiel reports 5.3% stake in AbCellera Bio

• AbCellera Biologics (NASDAQ:ABCL) perks up 2% premarket after Peter Thiel discloses 5.3% stake or holding of ~14.36M shares of the company.
• Thiel serves as a board member of the company and will be involved in reviewing transactions that may result in operational, strategic, financial